No abstract

No abstract

No abstract

At 12 months receipt of ICA had a significantly greater impact on mortality in NSTEMI (HR 0.37, CI:0.32, 0.42) than STEMI (HR 0.54, CI:0.45, 0.65), with mortality being 30% lower in both if revascularised (STEMI: HR 0.67, CI:0.55, 0.83; NSTEMI: HR 0.72, CI:0.61, 0.85). AMI readmission increased mortality, while readmission for TN-NSTEACS showed no effect on either.Conclusions: Over 12 months both STEMI and NSTEMI patients benefit from ICA during initial hospitalisation with the most benefit occurring in NSTEMI patients.

No abstract